NASDAQ:AQST Long Term Investor Notice: Investigation over Possible Wrongdoing at Aquestive Therapeutics, Inc.
An investigation on behalf of current long term investors in Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
San Diego, CA -- (SBWire) -- 05/24/2021 --Certain directors of Aquestive Therapeutics, Inc. are under investigation over possible breaches of fiduciary duties.
Investors who are current long term investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: AQST stocks follows a lawsuit filed against Aquestive Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AQST stocks, concerns whether certain Aquestive Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that, the Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups, that the foregoing significantly decreased the Libervant NDA's approval prospects, that as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Media Relations Contact
Michael Daniels
Shareholders Foundation
1-858-779-1554
https://www.shareholdersfoundation.com/
View this press release online at: http://rwire.com/1340122